Nuvectis Pharma, Inc. 8-K

What Happened
Nuvectis Pharma, Inc. (NVCT) filed a Form 8-K on May 5, 2026 to furnish a press release that provides a corporate update and announces the company’s financial results for the quarter ended March 31, 2026. The press release is being furnished as Exhibit 99.1 to the report.

Key Details

• Press release dated May 5, 2026 announcing financial results for the quarter ended March 31, 2026.
• The press release is furnished as Exhibit 99.1 to the Form 8-K.
• The filing states the information (including Exhibit 99.1) is furnished, not “filed,” and therefore is not subject to Section 18 liability and generally will not be incorporated by reference into other SEC filings.
• The Form 8-K includes the iXBRL cover page interactive data file (Exhibit 104).

Why It Matters
This filing signals that Nuvectis has publicly released its Q1 2026 quarterly results and a corporate update; investors should read the furnished press release for specifics on revenue, operating results, cash position, or guidance. Note the company designated the release as “furnished” (not “filed”), which limits certain legal liabilities and means the content won’t automatically become part of future SEC registration statements by reference.